Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 4, 1996, Pages 504-510

  Chen, Chien Jen ^a   Chiou, Hung Yi ^a   Chiang, Ming Hsi ^a   Lin, Li Ju ^a   Tai, Tong Yuan ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

arsenic; blackfoot disease; ischemic heart disease

Indexed keywords

ARSENIC;

ARTICLE; BLACKFOOT DISEASE; CARDIOVASCULAR RESPONSE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM EXPOSURE; MORTALITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TAIWAN;

EID: 0029872344     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.4.504     Document Type: Article

References (34)

1. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Some Metals and Metalloid Compounds. Vol 23. Lyon, France: International Agency for Research on Cancer; 1980:39-141.
2. World Health Organization. Environmental Health Criteria 18: Arsenic. Geneva, Switzerland: World Health Organization; 1981:43-102.
3. Smith AH, Hopehayn-Rich C, Bates MM, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Environ Health Perspect. 1992;97:259-267.
4. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977;19:110-119.
5. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988;8:452-460.
6. Tseng WP, Chen WY, Sung JL, Chen JS. A clinical study of blackfoot disease in Taiwan: an endemic peripheral vascular disease. Mem Coll Med Natl Taiwan Univ. 1961;7:1-18.
7. Borgono JM, Vincent P, Venturino H, Infante A. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of the treatment plant. Environ Health Perspect. 1977;19:103-105.
8. Cebrian ME. Some potential problems in assessing the effects of chronic arsenic poisoning in north Mexico. In: Preprints of Papers Presented at the American Chemical Society, Division of Environmental Chemistry, 194th Meeting. 1987:114-116.
9. Grobe JW. Peripheral circulatory disorders and acrocyanosis with arsenic [in German]. Berufs Dermatosen. 1976;24:78-84.
10. Lagerkvist BE, Linderholm H, Nordberg GF. Arsenic and Raynaud's phenomenon: vasospastic tendency and excretion of arsenic in smelter workers before and after the summer vacation. Int Arch Occup Environ Health. 1988;60:361-364.
11. Axelson O, Dahlgren E, Janssen CD, Rehnlund SO. Arsenic exposure and mortality: a case reference study from a Swedish copper smelter. Br J Ind Med. 1978;35:8-15.
12. Welch K, Higgins I, Oh M, Burchfiel C. Arsenic exposure, smoking, and respiratory cancer in copper smelter workers. Arch Environ Health. 1982;37:325-335.
13. Hansen ES. Mortality from cancer and ischemic heart disease in Danish chimney sweeps: a five-year follow-up. Am J Epidemiol. 1983;117:160-164.
14. Gustavsson P, Gustavsson A, Hogstedt C. Excess mortality among Swedish chimney sweeps. Br J Ind Med. 1987;44:738-743.
15. Wingren G, Axelson O, Mortality in the Swedish glassworks industry. Scand J Work Environ Health. 1987;13:412-416.
16. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancer and vascular disease. Am J Epidemiol. 1989;130:1123-1131.
17. Zaldivar R. A morbid condition involving cardiovascular, broncho-pulmonary, digestive and neural lesions in children and young adults after dietary arsenic exposure. Zentraibl Bakteriol. 1980;170:44-56.
18. Tsuda T, Nagira T, Yamamoto M. An epidemiological study on cancer in certified arsenic poisoning patients in Toroku. Ind Health. 1990;28:53-62.
19. Chen KP, Wu HY, Wu TC. Epidemiologic studies on blackfoot disease in Taiwan, 3: physicochemical characteristics of drinking water in endemic blackfoot disease areas. Mem Coll Med Natl Taiwan Univ. 1962;8:115-129.
20. Kuo TL. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Rep Inst Pathol Coll Med Natl Taiwan Univ. 1964;20:7-13.
21. Rothman KJ. Modern Epidemiology. Boston, Mass: Little, Brown & Co; 1986:29-32.
22. Lo MC, Hsen YC, Lin BK. Arsenic Content of Underground Water in Taiwan: Second Report. Taichung, Taiwan: Taiwan Provincial Institute of Environmental Sanitation; 1977:1-17.
23. Vach W, Blettner M. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol. 1991;134:895-907.
24. Weinberg CR. Toward a clearer definition of confounding. Am J Epidemiol. 1993;137:1-8.
25. Yeh SJ, Yang MH. Trace elements in water samples from the endemic area of blackfoot disease and biospecimens from blackfoot disease patients: a preliminary report. Blackfoot Dis Res Rep. 1980;8:22-28.
26. Lu FJ. Blackfoot disease: arsenic or humic acid. Lancet. 1990;336:115-116.
27. Chen CJ. Blackfoot disease. Lancet. 1990;336:442. Letter,
28. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 1994;139:484-492.
29. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL, Tai TY. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 1995;25:53-60.
30. Guha Mazumder DN, Chakraborty AK, Ghose A, Gupta JD, Chakraborty DP, Dey SB, Chattopadhyay N. Chronic arsenic toxieity from drinking tubewell water in rural west Bengal. Bull World Health Organ. 1988;66:499-506.
31. Hansen ES. Shared risk factors for cancer and atherosclerosis: a review of the epidemiological evidence. Mutat Res. 1990;239:163-179.
32. Lilienfeld DE. Arsenic, geographical isolates, environmental epidemiology, and atherosclerosis. Arteriosclerosis. 1988;8:449-451. Editorial.
33. Lopez S, Miyashita Y, Simons SS Jr. Structurally based, selective interaction of arsenite with steroid receptor. J Biol Chem. 1990;165:16039-16042.
34. Chen CJ, Lin LJ. Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic. In: Nriagu JO, ed. Arsenic in the Environment, Part II: Human Health and Ecosystem Effects. New York, NY: John Wiley & Sons, Inc; 1994:109-131.